2024 — Scientists uncovered an overlooked mechanism in the gut immune system of patients suffering from severe cases of Crohn's disease. The discovery may help define how to treat patients with ...
but they may not affect the progression of Crohn’s disease. In some cases, people stop taking antibiotics when they feel the side effects of the medication may be more severe than Crohn’s ...
Read on to find out more. Crohn’s disease is a chronic inflammation of the gastrointestinal tract (GIT). It’s categorized as an inflammatory bowel disease (IBD). Certain drinks and food have ...
The SEAVUE study looked at the efficacy and safety of ustekinumab versus adalimumab over the course of one year in biologic naive patients with moderate to severe Crohn's disease. They had a total ...
The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
If you have Crohn’s, your symptoms are more of a “choose your own adventure” situation. One person might have mild cramping ...
There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...
Crohn's disease is one such condition whose effects reach far beyond the intestines, influencing everything from your skin and bones to your mental health. This chronic condition can impact daily ...
People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential ...
In a 2007 study, researchers investigated natalizumab as a treatment for moderate to severe Crohn’s disease in 509 participants. They found that more participants in the treatment group than in ...
A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.
Agomab’s ALK5 inhibitor has proven its ability to target the correct part of the intestine in a phase 2 trial of ...